
Brammer Bio to set up new plant in Norton, Massachusetts
pharmafile | August 12, 2019 | News story | Sales and Marketing |Â Â Brammer Bio, Massachusetts, US, norton, pharmaÂ
Cambridge, Massachusetts-based Brammer Bio is planning to set up a new manufacturing facility in Norton, Massachusetts.
The Thermo Fisher subsidiary plans to employ 300 staff in its new Norton plant by 2021.
While the project is still in the preliminary stages, the cell and gene therapy firm plans to fund the new plant with tax increment financing (TIF), a public financing method used for redevelopment.
Brammer currently employs around 600 people in various locations, so will be increasing its stff by 50%.
In recent years Alnylam Pharmaceuticals also set up a $200 million plant in Norton’s industrial park.
Louis Goss
Related Content

Coriolis Pharma opens new US headquarter and laboratory
Coriolis Pharma has opened a new US headquarter and laboratory at the Alexandria Center for …

Abselion establishes a US subsidiary in MassachusettsÂ
Abselion has established a US subsidiary at The Engine in Cambridge, Massachusetts in the US. …

ESTEVE CDMO commences $15.5m expansion of US facility
ESTEVE CDMO, a global Contract Development and Manufacturing Organization (CDMO) specialising in small molecule active pharmaceutical …






